GlassScriptPhysician profile
Daniel Aaron Worrel
NPI 1720032477
$108,125.08
in general payments reported to CMS, 2019-2025
14 companies · $1,350 in 2025
The $1,350 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,968 · 2020: $91K · 2021: $6,295 · 2022: $2,657 · 2023: $238 · 2024: $2,191 · 2025: $1,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,853 · Travel and Lodging: $1,804 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75.00 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,852.57 |
| Travel and Lodging | $1,804.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75.00 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $91,084.83 | 2019-2025 | Oxford |
| Pylant Medical | $13,232.17 | 2019-2024 | |
| Arthrex, INC. | $2,288.95 | 2019-2024 | |
| Stryker Corporation | $1,105.30 | 2019-2025 | Iconix, Inspace, Salvation |
| Orthofix Medical, INC. | $112.12 | 2019-2024 | Physio-Stim |
| Depuy Synthes Sales INC. | $66.07 | 2019-2024 | Orthovisc, Monovisc |
| Horizon Therapeutics Plc | $52.52 | 2019-2020 | |
| Bioventus LLC | $44.45 | 2025 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $38.62 | 2023-2024 | Bone Anchors With Arthroscopic Delivery System |
| Ferring Pharmaceuticals INC. | $32.84 | 2019 | |
| Molnlycke Health Care US, LLC | $24.80 | 2024 | Mepilex Border Post-Op Ag, Avance |
| Terumo Bct, INC. | $21.56 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $20.85 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,132,803.65 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Worrel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.